A review of pediatric bacterial meningitis

Amy M. Pick, Desirae C. Sweet, Kimberley J. Begley

Research output: Contribution to specialist publicationArticle

1 Scopus citations

Abstract

Pediatric bacterial meningitis is a medical emergency requiring immediate initiation of treatment. Although the United States and other developed countries have seen a decline in pediatric meningitis, bacterial meningitis continues to cause high morbidity and mortality globally. Vaccinations (Haemophilus influenzae type b, pneumococcal, and meningococcal) have significantly reduced the risk of bacterial meningitis in developed countries. The treatment of bacterial meningitis depends on the suspected or known causative organism. Treatment often incorporates a third-generation cephalosporin or penicillin plus vancomycin. Dexamethasone may be added to prevent neurologic sequelae such as hearing loss. Despite aggressive therapy, many patients will experience long-term neurologic complications.

Original languageEnglish (US)
Pages41-45
Number of pages5
Volume41
No5
Specialist publicationU.S. Pharmacist
StatePublished - May 2016

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'A review of pediatric bacterial meningitis'. Together they form a unique fingerprint.

  • Cite this

    Pick, A. M., Sweet, D. C., & Begley, K. J. (2016). A review of pediatric bacterial meningitis. U.S. Pharmacist, 41(5), 41-45.